ArticleClinical and molecular hepatology2024

Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.

Xueshuai Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.